<a href="https://laohu8.com/S/CCRN">Cross Country Healthcare</a> Extends Merger End Date with Aya Holdings to December 2025
Cross Country Healthcare Inc. has announced an extension of the End Date for its merger with Aya Holdings II Inc. The End Date has been automatically extended from September 3, 2025, to December 3, 2025, as per the terms of the Merger Agreement dated December 3, 2024. The extension is part of the ongoing process in which Spark Merger Sub One Inc., a wholly owned subsidiary of Aya Holdings II Inc., will merge with and into Cross Country Healthcare. The terms of the Merger Agreement remain unchanged apart from the new End Date. Both companies have certified compliance with the U.S. Federal Trade Commission's Second Request for additional information, and subject to regulatory approvals and customary closing conditions, the merger is anticipated to be finalized in the fourth quarter of 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cross Country Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-25-011190), on September 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.